All these molecules exist as a soluble form and could interact with their receptors on monocytes: for example, sCTLA-4 could interact with CD80/86 and thereby prevent the binding with CD28 and T cell activation, as shown in autoimmune diseases [39]. Here, CD28 is linked to autoimmune disease.